Veraxa Biotech AG Ordinary Shares

VRXA XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

250M

Short interest (Jul 15)

0.2%

Net Short (Jul 27 ): 0.0%

Borrow Fee

150.59%

↑ 4.5%

Available Shares

70K

↓ 11.2%

Price Chart

Company Overview

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Company Info

Exchange: NASDAQ

CIK: 0002079109

Asset Type: CS

Market Data

Market Cap: $254,534,063

Status: Active

Short Interest

Current Borrow Fee 150.59%

Range: 107.37% - 150.59%

Available Shares 70K

Range: 40K - 100K

Recent Changes

Fee Change: ↑ 32.8%

Available Change: ↓ 25.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime